Literature DB >> 11966686

The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines.

E I Campos1, K-J J Cheung, A Murray, S Li, G Li.   

Abstract

BACKGROUND: Epidemiological evidence indicates that exposure to ultraviolet (UV) radiation is directly linked to the increase of both incidence and mortality of melanoma. However, the genetic changes caused by UV radiation that lead to melanoma formation remain poorly understood. Recently, a potential tumour suppressor gene ING1 (inhibitor of growth 1) was shown to inhibit cell growth and induce apoptosis in the presence of p53. We have demonstrated that the expression of ING1 is induced after UV irradiation and that ING1 enhances the repair of UV-damaged DNA.
OBJECTIVES: To investigate if ING1 plays a role in melanoma formation.
METHODS: We examined p33ING1 expression levels in 14 melanoma cell lines.
RESULTS: We found that p33ING1 is overexpressed at both mRNA and protein levels in melanoma cell lines compared with normal melanocytes. Single-strand conformation polymorphism (SSCP) analysis showed band shifting in two melanoma cell lines. DNA sequencing confirmed that there were nucleotide alterations in the ING1 gene in Sk-mel-24 and Sk-mel-110 cell lines. Two silent nucleotide alterations in exon 1a were detected in Sk-mel-110. In Sk-mel-24, the A-->G nucleotide alteration at codon 260 resulted in an amino acid change from Asn to Ser, while seven other nucleotide alterations were silent. To determine if the silent nucleotide alterations in these two melanoma cell lines were due to polymorphism, SSCP analysis of ING1 gene was performed in 25 healthy volunteers. No band shift was observed in the SSCP analysis, suggesting that the nucleotide alterations in the melanoma cell lines are unlikely to be due to polymorphism.
CONCLUSIONS: Taken together, our data demonstrate that ING1 is overexpressed, but infrequently mutated, in melanoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966686     DOI: 10.1046/j.1365-2133.2002.04641.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.

Authors:  Zhi Zhu; Jing Lin; Jian-Hui Qu; Mark-A Feitelson; Can-Rong Ni; Fang-Mei Li; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

2.  HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis.

Authors:  Xiaolan Feng; Shirin Bonni; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

3.  Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.

Authors:  Frauke Goeman; Dorit Thormeyer; Maria Abad; Manuel Serrano; Oliver Schmidt; Ignacio Palmero; Aria Baniahmad
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Genetic alterations and reduced expression of tumor suppressor p33(ING1b) in human exocrine pancreatic carcinoma.

Authors:  Guan-Zhen Yu; Ming-Hua Zhu; Zhi Zhu; Can-Rong Ni; Jian-Ming Zheng; Fang-Mei Li
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

Review 5.  The role of the tumour suppressor p33 ING1b in human neoplasia.

Authors:  G S Nouman; J J Anderson; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 6.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 7.  Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.

Authors:  Stuart J Gallagher; Jessamy C Tiffen; Peter Hersey
Journal:  Cancers (Basel)       Date:  2015-09-25       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.